highperformr logo

Adverum's Overview

Total employees27
HeadquartersRedwood City
Founded2004

Adverum Biotechnologies is a clinical-stage gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from serious ocular and rare diseases. Leveraging its proprietary adeno-associated virus (AAV)-based directed evolution platform, Adverum aims to engineer highly efficient and targeted gene therapies. Their primary focus includes treatments for conditions like wet age-related macular degeneration (wet AMD) and other ophthalmological disorders with significant unmet medical needs. The company is committed to advancing its pipeline through rigorous clinical trials and innovative research to bring potentially transformative therapies to patients.

Where is Adverum's Headquarters?

HQ Function

The headquarters serves as the central hub for Adverum's research and development, clinical operations, corporate administration, and strategic decision-making.

Notable Features:

State-of-the-art laboratory facilities for gene therapy research, including vector development and process sciences, along with modern office spaces designed to foster collaboration and innovation.

Work Culture:

Adverum promotes a work culture centered on scientific rigor, innovation, patient focus, and collaboration. Employees are driven by the potential to make a significant impact on patients' lives through cutting-edge gene therapy.

HQ Significance:

The Redwood City headquarters is pivotal for Adverum's mission, housing the core scientific and operational teams that drive the discovery, development, and potential commercialization of their gene therapy candidates.

Values Reflected in HQ: The headquarters embodies Adverum's commitment to pioneering science, innovation in gene therapy, and a patient-centric approach, reflected in its specialized R&D infrastructure and collaborative environment.

Location:

Adverum Biotechnologies' primary operations, including research, development, and corporate functions, are centered in the United States. While their physical presence is U.S.-based, their clinical trials may involve international sites, and their therapeutic focus on globally prevalent diseases like wet AMD implies a long-term vision for global patient impact and potential market reach upon successful drug approvals.

Street Address:

100 Cardinal Way

City:

Redwood City

State/Province:

CA

Country:

USA

Adverum's Global Presence

Redwood City, CA/USA

Address: 100 Cardinal Way, Redwood City, CA 94063

Serves as the global R&D and corporate hub.

Buying Intent Signals for Adverum

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Adverum

As of April 2025, Adverum' leadership includes:

Laurent Fischer, M.D. - President and Chief Executive Officer
Peter Soparkar, J.D., M.B.A. - Chief Operating Officer, General Counsel and Corporate Secretary
Setareh Seyedzadeh, Pharm.D., M.B.A. - Chief Business and Strategy Officer
Gustavo A. Diaz, M.D. - Chief Medical Officer

Investors of Adverum

Adverum has been backed by several prominent investors over the years, including:

The Sonic Fund II, L.P.
Commodore Capital
Perceptive Advisors
RA Capital Management
RTW Investments, LP
Venrock Healthcare Capital Partners
BlackRock
The Vanguard Group
Federated Hermes Kaufmann Funds

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits1

Over the past 12 months, Adverum Biotechnologies has seen key appointments strengthening its executive team, including a new Chief Medical Officer and a new Chief Business and Strategy Officer, alongside a role expansion for its General Counsel to COO. There was also a departure of the Chief Development Officer.

Departures

Rabia Gurses Ozden, M.D., Rabia Gurses Ozden, M.D., employment as Chief Development Officer terminated effective June 7, 2024.

New Appointments:

Gustavo A. Diaz, M.D., Gustavo A. Diaz, M.D., appointed as new Chief Medical Officer.
Setareh Seyedzadeh, Pharm.D., M.B.A., Setareh Seyedzadeh appointed as new Chief Business and Strategy Officer.
Peter Soparkar, J.D., M.B.A., Peter Soparkar transitioned to an expanded role as Chief Operating Officer, retaining General Counsel and Corporate Secretary duties.

Technology (Tech Stack) used by Adverum

Discover the tools Adverum uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Adverum Email Formats and Examples

Adverum Biotechnologies commonly uses the email format combining the first initial and last name. Other formats might exist but this is the most prevalent.

[first_initial][last]@adverum.com

Format

lfischer@adverum.com

Example

85%

Success rate

News and media

GlobeNewswireMay 21, 2024

Adverum Biotechnologies Appoints Gustavo A. Diaz, M.D. as Chief Medical Officer

Adverum Biotechnologies announced the appointment of Gustavo A. Diaz, M.D., as chief medical officer (CMO), effective May 20, 2024. Dr. Diaz will lead the company’s clinical development strategy and operations for its novel gene therapies....more

GlobeNewswireMay 9, 2024

Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Corporate Updates

Adverum reported financial results for Q1 2024, highlighting progress in its clinical programs, including Ixo-vec for wet AMD, and outlined key upcoming milestones. The company also noted the termination of employment for its Chief Development Officer, Rabia Gurses Ozden, M.D., effective June 7, 2024....more

GlobeNewswireJanuary 29, 2024

Adverum Biotechnologies Announces Role Expansion for Peter Soparkar, J.D., M.B.A., to Chief Operating Officer

Adverum announced the expansion of Peter Soparkar's role to Chief Operating Officer (COO), in addition to his existing responsibilities as General Counsel and Corporate Secretary. This change aims to enhance operational execution as the company advances its clinical programs....more

GlobeNewswireNovember 2, 2023

Adverum Biotechnologies Appoints Setareh Seyedzadeh, Pharm.D., M.B.A., as Chief Business & Strategy Officer

Adverum appointed Setareh Seyedzadeh as Chief Business and Strategy Officer to lead business development, corporate strategy, and portfolio planning....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Adverum, are just a search away.